Elon Musk and Sam Altman cofounded OpenAI, but now they're locked in a legal battle. Here's the history of their working relationship and feud.
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
Helion raises $425M to help build a fusion reactor for Microsoft
Helion's unorthodox approach to fusion power and relative secrecy has earned it plenty of fans — and critics. But don’t count ...
Sam Altman, SoftBank invest in $425M round for Helion, a Seattle-area startup chasing fusion power
Seattle-area company Helion Energy gets $425 million from investors including Sam Altman and Softbank to pursue clean ...
eWeek7d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
MIT Technology Review11d
OpenAI has created an AI model for longevity science
OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their ...
Sam Altman denies AGI release as reports swirl about US government meetings
With speculation online about OpenAI having reached the AGI stage of ChatGPT development, Sam Altman says that's not what's ...
DeepSeek Releases Janus Pro 7B Image Generation AI Model, Said to Outperform OpenAI’s DALL-E 3
Janus Pro 7B accepts text and images as input OpenAI CEO Sam Altman praised DeepSeek for its model releases Perplexity has ...
Hosted on MSN9mon
Sam Altman says we probably won't need a new device for the AI future
Sam Altman isn't sure the future of artificial intelligence requires new hardware. Despite a flurry of new devices hitting the market, the OpenAI CEO told MIT Technology Review we might not need ...
OpenAI is trying to extend human life, with help from a longevity startup
OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as ...